Our Projects
Discover our cutting-edge research and development projects advancing biotechnology solutions for global impact.
Mellivarin Project
Mellivarin is a novel antimicrobial peptide developed by Camellia Innovations for advanced wound healing and topical anti-infective applications. Through our international collaboration with leading peptide synthesis partners, Mellivarin has achieved full peptide synthesis, purification, and characterization, validated by an official Certificate of Analysis.
Goals & Impact
- Combat antimicrobial resistance (AMR)
- Introduce nature-inspired, safer therapeutic options
- Advance Africa's contribution to peptide-based drug discovery
- Move toward MIC testing, formulation development, and scalable preclinical evaluation
Milestones
- Provisional patent filed in South Africa
- Scientific validation and characterization completed
- Ready for the next phase of development and global translation
Deworming Capsule Project
This project focuses on developing a natural, bioactive deworming solution for both human and animal health. The formulation is based on a bioactive molecule extracted from seeds, currently under isolation and characterization.
Goals & Impact
- Provide an effective, safe, and natural alternative to conventional deworming treatments
- Support sustainable health practices in communities
- Develop a product suitable for scalable manufacturing and distribution
Current Stage
Bioactive molecule extraction and analysis underway. Preclinical efficacy and formulation studies planned. Preparing for pilot production and community-based trials.